4//SEC Filing
Skvarka Jan 4
Accession 0001725160-25-000135
CIK 0001725160other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 4:17 PM ET
Size
5.2 KB
Accession
0001725160-25-000135
Insider Transaction Report
Form 4
Skvarka Jan
Director
Transactions
- Award
Common Stock
2025-06-17+57,603→ 207,154 total
Footnotes (1)
- [F1]Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 17, 2026 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001838042
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 4:17 PM ET
- Size
- 5.2 KB